Implications of the New National Guidelines for Hypertension.

Abstract:

:Automated validated devices should be used for measuring blood pressure (BP). A systolic BP between 120 and 129 mm Hg with a diastolic BP < 80 mm Hg should be treated by lifestyle measures. Lifestyle measures plus BP lowering drugs should be used for secondary prevention of recurrent cardiovascular disease (CVD) events in persons with clinical CVD (coronary heart disease, congestive heart failure, and stroke) and an average systolic BP of ≥130 mm Hg or an average diastolic BP ≥ 80 mm Hg. Lifestyle measures plus BP lowering drugs should be used for primary prevention of CVD in persons with an estimated 10-year risk of atherosclerotic CVD ≥ 10% and an average systolic BP ≥130 mm Hg or an average diastolic BP ≥ 80 mm Hg. Lifestyle measures plus BP lowering drugs should be used for primary prevention of CVD in persons with an estimated 10-year risk of atherosclerotic CVD of <10% and an average systolic BP ≥ 140 mm Hg or an average diastolic BP ≥ 90 mm Hg. Initiate antihypertensive drug therapy with 2 first-line drugs from different classes either as separate agents or in a fixed-dose combination in persons with a BP ≥ 140/90 mm Hg or with a BP > 20/10 mm Hg above their BP target. White coat hypertension must be excluded before initiating treatment with antihypertensive drugs in persons with hypertension at low risk for atherosclerotic CVD. Antihypertensive drug treatment for different disorders is discussed.

journal_name

Cardiol Rev

journal_title

Cardiology in review

authors

Aronow WS,Frishman WH

doi

10.1097/CRD.0000000000000187

subject

Has Abstract

pub_date

2018-03-01 00:00:00

pages

55-61

issue

2

eissn

1061-5377

issn

1538-4683

pii

00045415-201803000-00001

journal_volume

26

pub_type

杂志文章,评审
  • Sudden Cardiac Death in Hypertrophic Cardiomyopathy.

    abstract::Hypertrophic cardiomyopathy (HCM) is a heart disease characterized by hypertrophy of the left ventricular myocardium and is most often caused by mutations in sarcomere genes. The structural and functional abnormalities are not explained by flow-limiting coronary artery disease or loading conditions. The disease affect...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000184

    authors: Adamczak DM,Oko-Sarnowska Z

    更新日期:2018-05-01 00:00:00

  • Chest pain from gastroesophageal reflux disease in patients with coronary artery disease.

    abstract::Management of patients with coronary artery disease is a major challenge for physicians, patients, and the healthcare system. Chest pain experienced by patients with coronary disease can be of noncardiac origin, and symptoms frequently related to gastroesophageal etiologies. The distal esophagus and the heart share a ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/01.crd.0000148844.13702.ce

    authors: Liuzzo JP,Ambrose JA

    更新日期:2005-07-01 00:00:00

  • Pulmonary hypertension in pregnancy.

    abstract::The presence of pulmonary arterial hypertension (PAH) in pregnancy is rare and signifies a high-risk pregnancy. Although the majority of mothers have knowledge of their condition before pregnancy, approximately one-third of patients are diagnosed during pregnancy. Termination of pregnancy should be discussed, and is o...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e318275cf01

    authors: Martínez MV,Rutherford JD

    更新日期:2013-07-01 00:00:00

  • Immune cells and molecular mediators in the pathogenesis of the abdominal aortic aneurysm.

    abstract::Abdominal aortic aneurysm is a multifactorial disease with genetic risk factors and an immunologic component. Immune cells, including macrophages, neutrophils, mast cells, B- and T- lymphocytes, along with vascular smooth muscle cells and adventitial fibroblasts, produce cytokines and enzymes, promoting an inflammator...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3181b04698

    authors: Rizas KD,Ippagunta N,Tilson MD 3rd

    更新日期:2009-09-01 00:00:00

  • Acute pericarditis: diagnostic cues and common electrocardiographic manifestations.

    abstract::Acute pericarditis (AP) is basically a clinical diagnosis. Although specific electrocardiographic (ECG) manifestations may indeed point to its diagnosis, sole reliance on such findings in isolation of the clinical setting, however, is often the common pitfall that could lead to a misguided diagnosis. We briefly review...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/01.crd.0000210645.89717.34

    authors: Ariyarajah V,Spodick DH

    更新日期:2007-01-01 00:00:00

  • Relaxin: a new approach for the treatment of acute congestive heart failure.

    abstract::Relaxin, a naturally-occurring hormone in the insulin family, was discovered to have a physiologic role in pregnancy. Named initially for its relaxing effect on the pubic ligament, relaxin receptors have since been found to be widely distributed in many organs in both males and females. Acting through multiple pathway...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3181f493e3

    authors: Grossman J,Frishman WH

    更新日期:2010-11-01 00:00:00

  • Reverse Remodeling in Systolic Heart Failure.

    abstract::Left ventricular (LV) remodeling is the most common term used to describe the functional, structural, myocellular, and interstitial changes that occur in response to myocardial injury and/or chronic changes in myocardial loading conditions. Progression of LV remodeling over time in response to neurohormonal activation...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000068

    authors: Saraon T,Katz SD

    更新日期:2015-07-01 00:00:00

  • Primary pulmonary hypertension and cor pulmonale.

    abstract::Primary pulmonary hypertension and cor pulmonale represent forms of precapillary pulmonary hypertension due to intrinsic lung disease. In the case of primary pulmonary hypertension, this is due to disease of the pulmonary vasculature while cor pulmonale is related to diseases of the pulmonary vasculature, airways, or ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200209000-00003

    authors: Lehrman S,Romano P,Frishman W,Rashid A,Dobkin J,Reichel J

    更新日期:2002-09-01 00:00:00

  • Ticagrelor: a novel reversible oral antiplatelet agent.

    abstract::The complex mechanism of platelet activation creates an optimal target for pharmacological treatment in patients with acute coronary syndromes. Current antiplatelet medications that are used in addition to aspirin include the thienopyridines, clopidogrel and prasugrel, but there are several limitations to the use of t...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3182099d86

    authors: Nawarskas JJ,Clark SM

    更新日期:2011-03-01 00:00:00

  • Successful thrombolysis of st. Jude medical aortic prosthesis with tissue-type plasminogen activator in a pregnant woman: a case report.

    abstract::Mechanical valve thrombosis is a life-threatening event. Pregnancy is associated with a hypercoagulable state that further emphasizes the importance of adequate anticoagulation. This is associated with a therapeutic dilemma. Continued anticoagulation with warfarin throughout the first trimester can result in fetopathi...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/00045415-200211000-00007

    authors: Behrendt P,Schwartzkopff B,Perings S,Gerhardt A,Zotz RB,Strauer BE

    更新日期:2002-11-01 00:00:00

  • Epigenetic regulation in heart failure: part II DNA and chromatin.

    abstract::Epigenetic regulatory mechanisms play key roles in cardiac development, differentiation, homeostasis, response to stress and injury, and disease. Human heart failure (HF) epigenetic regulatory mechanisms have not been deciphered to date. This 2-part review distills the rapidly evolving research focused on human HF epi...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000074

    authors: DiSalvo TG

    更新日期:2015-11-01 00:00:00

  • Gender differences and the outcome of interventions for acute coronary syndromes.

    abstract::Differences in the overall mortality for acute infarction in women vs men have been appreciated for some time. Some of these differences are based on the age at the time of presentation of women compared with men. Excess mortality in women is most clear at the younger end of the age spectrum. More careful examination ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200008040-00009

    authors: Feldman T,Silver R

    更新日期:2000-07-01 00:00:00

  • A novel approach to left atrial appendage exclusion: the WATCHMAN device.

    abstract::Atrial fibrillation (AF), a very common cardiac arrhythmia, is a well-recognized predisposing factor for embolic stroke. While warfarin remains the cornerstone of anticoagulant treatment in patients with AF, it is often underutilized because of increased bleeding complications and frequent monitoring requirements. It ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3181e53abb

    authors: Gorodnitskiy A,Lucariello RJ,Aizer A,Coppola JT

    更新日期:2010-09-01 00:00:00

  • Congenital heart disease in pregnancy.

    abstract::Care of pregnant patients with congenital heart disease requires understanding of the specific congenital defect, the nature of previous surgical correction, and the residua and sequelae. General risks and principles can be adduced in management decisions. In addition, lesion- and patient-specific details are importan...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200008030-00007

    authors: Colman JM,Sermer M,Seaward PG,Siu SC

    更新日期:2000-05-01 00:00:00

  • Coronary artery rupture associated with amphetamine abuse.

    abstract::We report a case of spontaneous coronary artery rupture associated with amphetamine abuse in a 31-year-old woman. The patient presented to the emergency department with sudden onset of central chest pain and a normal electrocardiogram. Cardiac enzymes were consistent with acute myocardial infarction. Drug screening wa...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/01.crd.0000132372.38506.45

    authors: Brennan K,Shurmur S,Elhendy A

    更新日期:2004-09-01 00:00:00

  • Is Anacetrapib Better Than Its CETP Inhibitor Counterparts?

    abstract::Cholesterol metabolism and transport has been a major focus in cardiovascular disease risk modification over the past several decades. Hydroxymethylglutaryl-CoA reductase inhibitors (statins) have been the most commonly used agents, with the greatest benefit in reducing both the primary and secondary risks of cardiova...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000245

    authors: Grabie M,Tai CH,Frishman WH

    更新日期:2019-09-01 00:00:00

  • Pulmonary artery hypertension: caveolin-1 and eNOS interrelationship: a new perspective.

    abstract::Pulmonary artery hypertension (PAH) is a sequela of a number of disparate diseases, often with a fatal consequence. Endothelial dysfunction is considered to be an early event during the development of PAH. Impaired availability of bioactive nitric oxide (NO) is a key underlying feature in most forms of clinical and ex...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/01.crd.0000249381.49138.b9

    authors: Mathew R,Huang J,Gewitz MH

    更新日期:2007-05-01 00:00:00

  • The prognostic impact of myocardial late gadolinium enhancement.

    abstract::Cardiovascular magnetic resonance using late gadolinium enhancement (LGE) provides a unique opportunity to assess myocardial tissue in vivo. LGE enables tissue characterization in ischemic and nonischemic cardiomyopathies and other cardiac diseases. LGE is associated with adverse clinical outcomes across a range of di...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000002

    authors: Panovsky R,Pleva M,Feitova V,Kruzliak P,Meluzin J,Kincl V

    更新日期:2014-05-01 00:00:00

  • What a physician needs to know about cost-effectiveness.

    abstract::The cost of medical care in the United States continues to spiral upward, partly as a result of new technological breakthroughs that promise improved length of life and quality of life for patients. But how good are these treatments in everyday practice? How do we make policies for adopting innovations that improve ou...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200008020-00006

    authors: Heidenreich PA,Lee TT

    更新日期:2000-03-01 00:00:00

  • Pacemakers and store security devices.

    abstract::The ever-increasing complexity of medical device therapy and installation of public electronic security systems demands vigilance in discerning interactions that may be harmful to patients during typical activities of daily living. Premature pacemaker stimulation, isolated skipped beats, or reversion to backup asynchr...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200101000-00004

    authors: Harthorne JW

    更新日期:2001-01-01 00:00:00

  • Toll-like receptors: new therapeutic targets for the treatment of atherosclerosis, acute coronary syndromes, and myocardial failure.

    abstract::The toll-like receptors (TLRs) are a class of transmembrane molecules that have important functions in both innate and acquired immunity. As part of the body's normal immune defense against microbial pathogens, stimulation of these receptors will trigger the inflammatory response cascade and the release of cytokines. ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3181709fd8

    authors: Erickson B,Sperber K,Frishman WH

    更新日期:2008-11-01 00:00:00

  • Percutaneous mitral heart valve repair--MitraClip.

    abstract::Mitral regurgitation (MR) is the most common cardiac valvular disease in the United States. Approximately 4 million people have severe MR and roughly 250,000 new diagnoses of MR are made each year. Mitral valve surgery is the only treatment that prevents progression of heart failure and provides sustained symptomatic ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000036

    authors: Doshi JV,Agrawal S,Garg J,Paudel R,Palaniswamy C,Doshi TV,Gotsis W,Frishman WH

    更新日期:2014-11-01 00:00:00

  • Women do benefit from lipid lowering: latest clinical trial data.

    abstract::Cardiovascular disease is the leading cause of morbidity and mortality among women in industrialized nations. Optimizing cardiovascular risk reduction is therefore of paramount importance, particularly among postmenopausal women, in whom the incidence of cardiovascular disease is highest. Accumulated data from a serie...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200301000-00003

    authors: Mostaghel E,Waters D

    更新日期:2003-01-01 00:00:00

  • Towards a Saphenous Vein Graft Moratorium.

    abstract::Atherosclerosis develops and rapidly progresses in saphenous veins grafts after coronary bypass surgery. In contrast to native coronary artery, percutaneous revascularization does not impede the progression of saphenous vein atherosclerosis and saphenous vein graft failure commonly ensues. The protracted patency of ar...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/CRD.0000000000000277

    authors: Motwani A,Ayinapudi K,Singh T,Maini R,Hendel R,Le Jemtel TH

    更新日期:2020-09-01 00:00:00

  • Perspectives on sudden death prevention in hypertrophic cardiomyopathy.

    abstract::Sudden death (SD) is the most dramatic event in hypertrophic cardiomyopathy (HCM), often representing the first clinical manifestation of the disease, and the first concern of the clinicians who take care of such patients. HCM is now recognized as the primary cause of SD in young persons (<35 years of age), including ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000017

    authors: Efthimiadis GK,Zegkos T,Meditskou S,Hadjimiltiades S

    更新日期:2014-09-01 00:00:00

  • Cardiac rupture after myocardial infarction: new insights from murine models.

    abstract::Cardiac rupture after a myocardial infarction is an uncommon event with devastating consequences. Although the clinical features of rupture have been described, the genetic and molecular influences on this outcome in patients are less certain. In mice, at least 17 genetic models have been developed that enhance or sup...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3181bf4ab4

    authors: Sane DC,Mozingo WS,Becker RC

    更新日期:2009-11-01 00:00:00

  • Newer anticoagulants in cardiovascular disease: a systematic review of the literature.

    abstract::Vitamin K antagonists (VKAs) such as warfarin have traditionally been the major therapeutic option for anticoagulation in clinical practice. VKAs are effective and extensively recommended for the prevention of venous and arterial thromboembolism in cardiovascular disease. Despite its effectiveness, warfarin is limited...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3182503e2d

    authors: Maan A,Padmanabhan R,Shaikh AY,Mansour M,Ruskin JN,Heist EK

    更新日期:2012-09-01 00:00:00

  • Idiopathic pulmonary arterial hypertension in childhood.

    abstract::The introduction of new medicines to treat pulmonary vascular disease has renewed interest in the management of children with idiopathic pulmonary arterial hypertension. We now have a practical classification of pulmonary hypertension, improved diagnostic techniques, and internationally recognized diagnostic and manag...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3181ce03df

    authors: Haworth SG

    更新日期:2010-03-01 00:00:00

  • Optimization of radiation dose reduction in cardiac computed tomographic angiography.

    abstract::Cardiac computed tomographic angiography (CCTA) has evolved at an unprecedented pace over the past decade, during which time it has proven to be an accurate and effective tool for imaging of the heart in a growing list of clinical applications. However, the rapid growth in the use of CT imaging in general has prompted...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e31821daa8f

    authors: Entrikin DW,Leipsic JA,Carr JJ

    更新日期:2011-07-01 00:00:00

  • A Review of Remdesivir for COVID-19: Data to Date.

    abstract::Severe acute respiratory coronavirus-2 (SARS-CoV-2) is responsible for one of the greatest public health challenges of our lifetime, the coronavirus disease 2019 (COVID-19) pandemic. Because of the complicated postinfection sequelae and grave consequences, the search for effective therapies has become a worldwide prio...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000337

    authors: Mehta M,Shyh GI

    更新日期:2020-11-01 00:00:00